122 related articles for article (PubMed ID: 20098111)
1. Metachronous primary melanoma and lymphoma.
McIntosh BC; Ariyan S; Esche G; Zelterman D; Narayan D
Ann Plast Surg; 2010 Feb; 64(2):229-32. PubMed ID: 20098111
[TBL] [Abstract][Full Text] [Related]
2. Second lymphomas and other malignant neoplasms in patients with mycosis fungoides and Sezary syndrome: evidence from population-based and clinical cohorts.
Huang KP; Weinstock MA; Clarke CA; McMillan A; Hoppe RT; Kim YH
Arch Dermatol; 2007 Jan; 143(1):45-50. PubMed ID: 17224541
[TBL] [Abstract][Full Text] [Related]
3. The association between malignant melanoma and noncutaneous malignancies.
Wu YH; Kim GH; Wagner JD; Hood AF; Chuang TY
Int J Dermatol; 2006 May; 45(5):529-34. PubMed ID: 16700785
[TBL] [Abstract][Full Text] [Related]
4. Review of contemporaneous mycosis fungoides and B-cell malignancy at Mayo Clinic.
Herro E; Dicaudo DJ; Davis MD; Weaver AL; Swanson DL
J Am Acad Dermatol; 2009 Aug; 61(2):271-5. PubMed ID: 19481294
[TBL] [Abstract][Full Text] [Related]
5. Mycosis fungoides associated with B-cell malignancies.
Barzilai A; Trau H; David M; Feinmesser M; Bergman R; Shpiro D; Schiby G; Rosenblatt K; Or R; Hodak E
Br J Dermatol; 2006 Aug; 155(2):379-86. PubMed ID: 16882178
[TBL] [Abstract][Full Text] [Related]
6. Screening for second malignancies in mycosis fungoides: non-Hodgkin lymphoma, Hodgkin lymphoma, lung cancer, bladder cancer and melanoma.
Goyal A; O'Leary D; Goyal K; Rubin N; Janakiram M
J Eur Acad Dermatol Venereol; 2021 Sep; 35(9):1821-1829. PubMed ID: 34013554
[TBL] [Abstract][Full Text] [Related]
7. Does solar exposure, as indicated by the non-melanoma skin cancers, protect from solid cancers: vitamin D as a possible explanation.
Tuohimaa P; Pukkala E; Scélo G; Olsen JH; Brewster DH; Hemminki K; Tracey E; Weiderpass E; Kliewer EV; Pompe-Kirn V; McBride ML; Martos C; Chia KS; Tonita JM; Jonasson JG; Boffetta P; Brennan P
Eur J Cancer; 2007 Jul; 43(11):1701-12. PubMed ID: 17540555
[TBL] [Abstract][Full Text] [Related]
8. Malignant melanoma and other second cutaneous malignancies in cutaneous T-cell lymphoma. The influence of additional therapy after total skin electron beam radiation.
Licata AG; Wilson LD; Braverman IM; Feldman AM; Kacinski BM
Arch Dermatol; 1995 Apr; 131(4):432-5. PubMed ID: 7726585
[TBL] [Abstract][Full Text] [Related]
9. Trends in cancer incidence in Connecticut.
Polednak AP
Conn Med; 1997 Apr; 61(4):211-8. PubMed ID: 9149483
[TBL] [Abstract][Full Text] [Related]
10. Multiple primary melanomas: an analysis of cancer registry data from Victoria and New South Wales.
Giles G; Staples M; McCredie M; Coates M
Melanoma Res; 1995 Dec; 5(6):433-8. PubMed ID: 8589618
[TBL] [Abstract][Full Text] [Related]
11. A population-based analysis of risk factors for a second primary cutaneous melanoma among melanoma survivors.
Goggins WB; Tsao H
Cancer; 2003 Feb; 97(3):639-43. PubMed ID: 12548605
[TBL] [Abstract][Full Text] [Related]
12. Second primary neoplasms following non-Hodgkin's lymphoma in New South Wales, Australia.
Brennan P; Coates M; Armstrong B; Colin D; Boffetta P
Br J Cancer; 2000 Apr; 82(7):1344-7. PubMed ID: 10755412
[TBL] [Abstract][Full Text] [Related]
13. Cutaneous T-cell lymphoma is associated with increased risk of lymphoma, melanoma, lung cancer, and bladder cancer.
Goyal A; O'Leary D; Goyal K; Patel K; Pearson D; Janakiram M
J Am Acad Dermatol; 2021 Dec; 85(6):1418-1428. PubMed ID: 32822803
[TBL] [Abstract][Full Text] [Related]
14. Melanoma and additional primary cancers.
Retsas S; Mohith A; Bell J; Horwood N; Alexander H
Melanoma Res; 2000 Apr; 10(2):145-52. PubMed ID: 10803715
[TBL] [Abstract][Full Text] [Related]
15. The risk of subsequent primary carcinoma of the pancreas in patients with cutaneous malignant melanoma.
Schenk M; Severson RK; Pawlish KS
Cancer; 1998 May; 82(9):1672-6. PubMed ID: 9576287
[TBL] [Abstract][Full Text] [Related]
16. Development of prognostic factors and survival in cutaneous melanoma over 25 years: An analysis of the Central Malignant Melanoma Registry of the German Dermatological Society.
Buettner PG; Leiter U; Eigentler TK; Garbe C
Cancer; 2005 Feb; 103(3):616-24. PubMed ID: 15630700
[TBL] [Abstract][Full Text] [Related]
17. Renal parenchymal tumors and lymphoma in the same patient: case series and review of the literature.
Kunthur A; Wiernik PH; Dutcher JP
Am J Hematol; 2006 Apr; 81(4):271-80. PubMed ID: 16550521
[TBL] [Abstract][Full Text] [Related]
18. Cutaneous melanoma in Connecticut towns, 1989-91.
Polednak AP
Conn Med; 1994 Sep; 58(9):523-6. PubMed ID: 7956198
[TBL] [Abstract][Full Text] [Related]
19. Cutaneous malignant melanoma in association with mycosis fungoides.
Evans AV; Scarisbrick JJ; Child FJ; Acland KM; Whittaker SJ; Russell-Jones R
J Am Acad Dermatol; 2004 May; 50(5):701-5. PubMed ID: 15097953
[TBL] [Abstract][Full Text] [Related]
20. Incidence of primary cutaneous T-cell lymphoma in Norway.
Saunes M; Nilsen TI; Johannesen TB
Br J Dermatol; 2009 Feb; 160(2):376-9. PubMed ID: 18808419
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
